BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma
Objectives: Plasmablastic myeloma (PBM) is a variant of multiple myeloma associated with a poor prognosis. We investigated the efficacy and safety of B-cell maturation antigen (BCMA) chimeric antigen receptor T cell (CAR-T) therapy in patients with PBM.Methods: The study comprised six patients diagn...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2025-12-01
|
| סדרה: | Hematology |
| נושאים: | |
| גישה מקוונת: | https://www.tandfonline.com/doi/10.1080/16078454.2025.2481555 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|